http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201692221-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate | 2015-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201692221-A1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DISEASES RELATED TO THE INCREASED ACTIVITY OF INDUCED SYNTHASE OF NITROGEN OXIDE |
| abstract | This invention relates to a new medical use of (4R) -2- (4-phenyl-2-oxopyrrolidin-1-yl) acetamide for the treatment of conditions characterized by increased expression of the iNOS gene. |
| priorityDate | 2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559537 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945 |
Total number of triples: 15.